SUBSCRIBERS
EDBI joins investors in US$500m funding for US biotech unicorn
Add BT as a preferred sourcePublished Fri, Feb 2, 2018 · 09:50 PM
Singapore
EDBI, the investment arm of the Singapore Economic Development Board, has joined a group of investors in a US$500 million funding round for US biotech Moderna Therapeutics.
Other new investors include a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA), BB Biotech AG, Julius Baer and Sequoia Capital China. Existing investors that also participated in this round include Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.
